B-CELL ALL
Clinical trials for B-CELL ALL explained in plain language.
Never miss a new study
Get alerted when new B-CELL ALL trials appear
Sign up with your email to follow new studies for B-CELL ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Donor immune cells show promise against relapsed blood cancers
Disease control OngoingThis early-phase study tests a new treatment for people with certain blood cancers (lymphoma or leukemia) that have returned after a stem cell transplant. Researchers take immune cells (T cells) from the original stem cell donor, modify them to recognize and attack cancer cells c…
Matched conditions: B-CELL ALL
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 08:10 UTC
-
Can anakinra stop CAR-T's dangerous side effects?
Disease control OngoingThis study tests whether the drug anakinra can prevent or reverse severe side effects from CAR-T cell therapy, a treatment for certain blood cancers. About 62 adults with relapsed B-cell cancers will receive anakinra alongside their CAR-T treatment. The goal is to reduce serious …
Matched conditions: B-CELL ALL
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:10 UTC